Maze Therapeutics’ (NASDAQ:MAZE – Get Free Report) quiet period will expire on Wednesday, March 12th. Maze Therapeutics had issued 8,750,000 shares in its initial public offering on January 31st. The ...
March update transforms its core systems, with smarter looting, more adept enemy AI, slicker gunplay, and a water rework.